Agilent Technologies, Inc.
Agilent Technologies, Inc.
A
Valuace
26
Růst
71
Zdraví
84
Cena
$ 146.16
Dnes
--5.19 (-3.58%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
41.4B
Obrat
7B
Zisk
1B
Aktiva
12B
Dluh
3B
ROE
0%
ROA
0%
PE
25
PS
4
Cena 1R
96-160
⌀ Cena
126.40
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
25-02-2026
Poslední dividenda
31-03-2026

Profil

Společnost Agilent Technologies, Inc. poskytuje aplikační řešení zaměřená na vědy o živé přírodě, diagnostiku a aplikované chemické trhy po celém světě. Segment Life Sciences and Applied Markets nabízí systémy a komponenty kapalinové chromatografie; systémy a komponenty kapalinové chromatografie hmotnostní spektrometrie; systémy a komponenty plynové chromatografie; systémy plynové chromatografie hmotnostní spektrometrie; přístroje s indukčně vázanou plazmovou hmotnostní spektrometrií; atomové absorpční přístroje; přístroje mikrovlnné plazmovo-atomové emisní spektrometrie; přístroje s indukčně vázanou plazmovou optickou emisní spektrometrií; ramanovou spektrometrii; testy založené na buněčných analytických deskách; průtorový cytometr; analyzátor buněk v reálném čase; systémy; systémy zobrazování buněk; systémy; systémy; systémy zobrazovacích buněk; laboratorní automatizační a robotické systémy; testování rozpouštění; vakuové vývěvy a měřicí technologie. Segment diagnostiky a genomiky poskytuje pole pro detekci mutací DNA, genotypizaci, určení počtu kopií genů, identifikaci rearanžmá genů, profilaci methylace DNA, profilaci exprese genů, sekvenování další generace, obohacování cílů a správu genetických dat a software na podporu interpretace a produkuje syntetizovaný oligonukleotid. Nabízí také imunohistochemii v hybridizaci in situ a barvení hematoxylinem a eosinem a speciální barvení; spotřební materiál a software pro analýzu kontroly kvality vzorků nukleové kyseliny; a činidla pro použití v turbidimetrii a průtokové cytometrii, stejně jako vyvíjí farmakodiagnostiku na bázi tekutin. Segment Agilent CrossLab poskytuje sloupce GC a LC, produkty pro přípravu vzorků, vlastní chemie a laboratorní vybavení přístrojů; a startovací, provozní, školení, podporu dodržování předpisů, software jako služba, správu majetku a konzultační služby. Společnost prodává své výrobky prostřednictvím přímého prodeje, distributorů, prodejců, zástupců výrobců a elektronického obchodu. Agilent Technologies, Inc. byla založena v roce 1999 a sídlí v Santa Clara v Kalifornii.
Sektor
Healthcare
Odvětví
Medical - Diagnostics & Research
Počet zaměstnanců
17900
Založení
1999-11-18
Adresa
5301 Stevens Creek Boulevard
CEO
Padraig McDonnell

Podobné společnosti

$ 211.92
+ $ 1.46
$ 74.07
+ $ 0.10
$ 248.57
- $ 2.92
$ 9.54
+ $ 0.08
$ 202.89
- $ 0.78

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues7,065.06,948.06,510.06,833.06,848.06,319.05,339.05,163.04,914.04,472.04,202.04,038.06,981.06,782.06,858.06,615.05,444.0
Cost of Revenues3,375.03,305.02,975.03,368.03,126.02,912.02,502.02,358.02,227.02,063.02,005.01,997.03,388.03,247.03,254.03,086.02,514.0
Gross Profit3,690.03,643.03,535.03,465.03,722.03,407.02,837.02,805.02,687.02,409.02,197.02,041.03,593.03,535.03,604.03,529.02,930.0
Revenue 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Total Revenues1,798.01,861.01,738.01,668.01,681.01,701.01,578.01,573.01,658.01,688.0
Cost of Revenues852.0897.0824.0802.0782.0785.0723.0717.0750.0773.0
Gross Profit946.0964.0914.0866.0899.0916.0855.0856.0908.0915.0
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0481.0467.0441.0495.0404.0385.0339.0329.0330.0719.0704.0668.0649.0612.0
Selling General & Admin Expenses0.00.00.01,634.01,637.01,619.01,496.01,460.01,374.01,229.01,253.01,189.02,043.01,880.01,817.01,809.01,752.0
Depreciation & Amortization283.0288.0257.0271.0287.0415.0382.0290.0210.0212.0246.0253.0383.0372.0301.0253.0202.0
Total Operating Expenses2,234.02,164.02,047.02,115.02,104.02,060.01,991.01,864.01,759.01,568.01,582.01,519.02,762.02,584.02,485.02,458.02,364.0
Operating Income1,456.01,479.01,488.01,350.01,618.01,347.0846.0941.0928.0841.0615.0522.0831.0951.01,119.01,071.0566.0
Operating Income TTM 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
R&D Expenses0.00.00.00.00.00.00.00.00.0114.0
Selling General & Admin Expenses0.00.00.00.00.00.00.00.00.0393.0
Depreciation & Amortization67.071.072.073.072.069.063.063.062.062.0
Total Operating Expenses593.0521.0554.0566.0523.0508.0522.0493.0524.0507.0
Operating Income353.0443.0360.0300.0376.0408.0333.0363.0384.0408.0
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income62.062.080.051.09.02.08.036.038.022.011.07.09.07.09.014.020.0
Interest Expense109.0112.096.095.084.081.078.074.075.079.072.066.0113.0107.0101.086.096.0
Other Expense-24.0-44.033.0-11.0-114.013.0-4.0-22.055.019.0-10.017.0-81.08.016.033.0202.0
IBT1,432.01,435.01,521.01,339.01,504.01,360.0842.0919.0946.0803.0544.0480.0646.0859.01,043.01,032.0692.0
Income Tax Expense142.0132.0232.099.0250.0150.0123.0-152.0630.0119.084.045.0149.0135.0-110.020.068.0
Net Income1,290.01,303.01,289.01,240.01,254.01,210.0719.01,071.0316.0684.0460.0398.0497.0724.01,153.01,012.0624.0
Net Income TTM 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Interest Income15.017.016.014.015.024.019.019.018.017.0
Interest Expense25.027.028.029.028.032.022.020.022.022.0
Other Expense11.0-1.06.0-40.0-9.0-7.010.011.019.012.0
IBT364.0442.0366.0260.0367.0401.0343.0374.0403.0420.0
Income Tax Expense59.08.030.045.049.050.061.066.055.0-55.0
Net Income305.0434.0336.0215.0318.0351.0282.0308.0348.0475.0
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$4.22$4.19$3.98$2.33$3.41$0.98$2.12$1.41$1.20$1.49$2.12$3.31$2.92$1.80
EPS Diluted$0.00$0.00$0.00$4.19$4.18$3.94$2.30$3.37$0.97$2.10$1.40$1.19$1.47$2.10$3.27$2.85$1.77
Shares Outstanding283.0283.0290.0294.0299.0304.0309.0314.0321.0322.0326.0333.0333.0341.0348.0347.0347.0
Diluted Shares Outstanding284.0284.0291.0296.0300.0307.0312.0318.0325.0326.0329.0335.0338.0345.0353.0355.0353.0
Per Share Data TTM 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.63
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.62
Shares Outstanding283.0283.0285.0285.0285.0290.0290.0293.0293.0292.0
Diluted Shares Outstanding284.0284.0285.0285.0287.0291.0291.0293.0294.0293.0
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents1,779.01,329.01,590.01,053.01,484.01,441.01,382.02,247.02,678.02,289.02,003.03,028.02,675.02,351.03,527.02,649.0
Short Term Investments0.00.00.00.091.00.00.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments1,779.01,329.01,590.01,053.01,575.01,441.01,382.02,247.02,678.02,289.02,003.03,028.02,675.02,351.03,527.02,649.0
Accounts Receivable1,227.01,324.01,291.01,405.01,172.01,038.0930.0776.0724.0624.0606.0983.0899.0923.0860.0869.0
Inventory978.0991.01,031.01,038.0830.0720.0679.0638.0575.0533.0541.01,072.01,066.01,014.0898.0716.0
Other Current Assets272.0315.0274.0282.0222.0216.0198.0187.0192.0189.0294.0376.0329.0341.0292.0385.0
Total Current Assets4,256.03,959.04,186.03,778.03,799.03,415.03,189.03,848.04,169.03,635.03,686.05,459.04,969.04,629.05,577.06,169.0
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents1,535.01,486.01,467.01,329.01,779.01,671.01,748.01,590.01,329.01,175.0
Short Term Investments0.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments1,535.01,486.01,467.01,329.01,779.01,671.01,748.01,590.01,329.01,175.0
Accounts Receivable1,382.01,366.01,328.01,324.01,227.01,249.01,295.01,291.01,339.01,401.0
Inventory1,014.0991.0997.0972.0978.01,000.01,033.01,031.01,072.01,103.0
Other Current Assets322.0365.0315.0334.0272.0283.0262.0274.0290.0270.0
Total Current Assets4,253.04,208.04,107.03,959.04,256.04,203.04,338.04,186.04,030.03,949.0
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment1,446.01,955.01,424.01,100.0945.0845.0850.0822.0757.0639.0604.01,101.01,134.01,164.01,006.0980.0
Goodwill3,965.04,474.03,960.04,773.04,956.04,433.04,700.03,464.02,607.02,517.02,366.02,899.03,047.03,025.01,567.01,456.0
Intangible Assets392.0547.0475.0821.0981.0831.01,107.0491.0361.0408.0445.0667.0916.01,086.0429.0494.0
Long-Term Investments189.0175.0164.0195.0185.0158.0102.068.0138.0135.086.0159.0139.0109.0117.0142.0
Other Long-Term Assets748.0297.0554.0670.0820.0776.0611.0339.0397.0483.0289.0475.0481.0523.0361.0403.0
Total Long-Term Assets6,740.07,887.06,577.06,738.06,906.06,212.06,263.04,693.04,260.04,182.03,790.05,301.05,717.05,907.03,480.03,475.0
Total Assets10,996.011,846.010,763.010,516.010,705.09,627.09,452.08,541.08,429.07,817.07,476.010,760.010,686.010,536.09,057.09,644.0
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment1,966.01,912.01,816.01,955.01,446.01,371.01,314.01,270.01,211.01,184.0
Goodwill4,475.04,474.04,429.04,477.03,965.03,963.03,967.03,960.03,984.03,980.0
Intangible Assets469.0495.0514.0547.0392.0417.0443.0475.0502.0821.0
Long-Term Investments135.0135.0173.0175.0186.0177.0170.0164.0190.0186.0
Other Long-Term Assets928.0934.0875.0297.0751.0725.0716.0708.0758.0695.0
Total Long-Term Assets7,973.07,950.07,807.07,887.06,740.06,653.06,610.06,577.06,645.06,866.0
Total Assets12,226.012,158.011,914.011,846.010,996.010,856.010,948.010,763.010,675.010,792.0
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable497.0540.0418.0580.0446.0354.0354.0340.0305.0257.0279.0475.0432.0461.0472.0499.0
Short-Term Debt795.087.00.036.00.075.0616.00.0210.0-1.010.0-51.00.0250.0253.01,501.0
Other Current Liabilities573.0724.0607.0784.0821.0652.0774.0507.0457.0419.0439.0792.0731.0762.0723.0725.0
Current Liabilities2,389.01,895.01,603.01,861.01,708.01,467.02,080.01,171.01,263.0944.0986.01,651.01,602.01,893.01,837.03,083.0
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable530.0517.0547.0540.0497.0461.0488.0418.0452.0479.0
Short-Term Debt59.0146.016.045.0795.0420.00.046.055.00.0
Other Current Liabilities683.0721.0694.0766.0573.0544.0607.0634.0741.0668.0
Current Liabilities1,892.02,012.01,869.01,895.02,389.01,958.01,617.01,603.01,760.01,666.0
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt2,137.03,487.02,853.02,733.02,729.02,284.01,791.01,799.01,801.01,912.01,655.02,762.02,699.02,112.01,932.02,190.0
Capital Leases0.0184.0164.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Liabilities5,093.05,948.04,918.05,227.05,316.04,754.04,704.03,970.03,599.03,573.03,318.05,473.05,397.05,351.04,741.06,460.0
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt3,350.03,349.03,347.03,345.02,137.02,136.02,555.02,735.02,734.02,733.0
Capital Leases0.00.00.00.0184.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities5,856.06,022.05,887.05,948.05,093.04,642.04,760.04,918.05,117.05,011.0
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock3.03.03.03.03.03.03.03.03.06.06.06.06.06.06.06.0
Retained Earnings773.0750.0782.0324.0348.081.0-18.0-336.0-126.06,087.05,581.06,459.06,073.05,505.04,456.03,384.0
Comprehensive Income-331.0-305.0-327.0-363.0-282.0-522.0-514.0-408.0-352.0-503.0-401.0-340.091.0-111.0116.0-80.0
Total Common Equity5,903.05,898.05,845.05,289.05,389.04,873.04,748.04,567.04,826.04,241.04,155.05,284.05,286.05,182.04,308.03,176.0
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock3.03.03.03.03.03.03.03.03.03.0
Retained Earnings1,102.0912.0916.0750.0773.01,090.01,061.0782.0444.0700.0
Comprehensive Income-283.0-280.0-381.0-305.0-331.0-337.0-316.0-327.0-271.0-282.0
Total Common Equity6,370.06,136.06,027.05,898.05,903.06,214.06,188.05,845.05,558.05,781.0
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt2,932.03,574.02,735.02,769.02,729.02,359.02,407.01,799.02,011.01,912.01,655.02,762.02,699.02,362.02,185.03,691.0
Book Value5,903.05,898.05,845.05,289.05,389.04,873.04,748.04,571.04,830.04,244.04,158.05,287.05,289.05,185.04,316.03,184.0
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value6,370.06,136.06,027.05,898.05,903.06,214.06,188.05,845.05,558.05,781.0
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income1,413.0434.01,289.01,240.01,254.01,210.0719.01,071.0316.0684.0460.0398.0497.0724.01,153.01,012.0624.0
Depreciation & Amortization250.0288.0257.0271.0317.0321.0308.0238.0210.0212.0246.0253.0383.0372.0301.0253.0202.0
Stock-Based Compensation117.0128.0129.0111.0125.0110.083.072.070.060.058.054.096.084.074.072.066.0
Change Working Capital-36.0-58.083.0-116.0-478.0-88.0-296.0-388.0455.0-98.0-25.0-255.0-341.0-82.0-334.0-122.0-109.0
Change In Accounts Receivable86.0-149.07.0132.0-321.0-128.0-107.0-106.0-65.0-81.0-26.0-24.0-119.014.019.011.0-166.0
Change In Accounts Payable24.016.0103.0-171.0121.064.02.030.040.02.0-15.0-26.050.0-27.0-31.0-35.0113.0
Change In Inventories35.045.034.0-33.0-248.0-136.0-68.0-36.0-83.0-61.0-7.0-24.0-99.0-100.0-52.0-208.0-51.0
Other Non-cash Items468.0897.057.0322.086.0-82.078.0283.052.0-71.051.0-29.0210.023.0192.07.038.0
Cash from Operations1,786.00.00.01,772.01,312.01,485.0921.01,021.01,087.0889.0793.0491.0713.01,152.01,228.01,260.0712.0
Cash Flow From Operating Activities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Net Income305.0434.0336.0215.0318.0351.0282.0308.0348.0475.0
Depreciation & Amortization67.071.072.073.072.069.063.063.062.062.0
Stock-Based Compensation41.026.032.030.040.025.028.032.044.014.0
Change Working Capital-180.085.0-82.0-136.02.046.066.0-75.021.0-48.0
Change In Accounts Receivable-18.0-105.0-17.03.0-30.0-60.023.034.010.019.0
Change In Accounts Payable39.029.014.0-30.03.025.014.0-20.084.0-54.0
Change In Inventories-39.0-25.0-31.0-1.0-40.019.012.012.0-9.020.0
Other Non-cash Items10.024.011.057.09.0-10.014.012.0115.0153.0
Cash from Operations0.00.00.00.00.00.00.00.00.0516.0
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-369.0-207.0-378.0-298.0-291.0-189.0-119.0-156.0-177.0-176.0-139.0-98.0-207.0-195.0-193.0-188.0-119.0
Acquisitions47.04.0-862.0-1.0-52.0-546.00.0-1,408.0-516.0-126.0-264.0-72.0-36.0-42.0-2,263.0-97.0-1,313.0
Investments-10.00.0-5.0-8.0-13.0-22.0-20.0-23.0-11.0-1.0-80.00.014.0-25.00.00.0-30.0
Sales of Investment0.08.00.05.022.012.00.0-1.01.00.01.00.01.012.05.016.038.0
Other Investing Activities-12.00.00.0-8.0-4.0-4.0-8.0-2.0-1.0-2.0244.0-230.0-4.02.080.01,563.0253.0
Cash from Investing-344.00.00.0-310.0-338.0-749.0-147.0-1,590.0-704.0-305.0-238.0-400.0-232.0-248.0-2,371.01,294.0-1,171.0
Cash Flow From Investing Activities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Capital Expenditure-93.0-93.0-103.0-114.0-97.0-93.0-92.0-103.0-90.0-84.0
Acquisitions0.00.00.00.04.0-859.0-3.00.00.050.0
Investments0.00.00.00.00.05.0-2.0-3.00.0-5.0
Sales of Investment0.03.00.00.00.00.00.00.00.00.0
Other Investing Activities0.00.00.00.00.00.00.00.00.0-1.0
Cash from Investing0.00.00.00.00.00.00.00.00.0-40.0
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-610.00.00.0-35.0-1,869.0-2,139.0-1,762.0-512.0-693.0-290.0-292.00.0-1,087.0-250.0-251.0-1,500.0-29.0
Debt Issued753.03,574.0839.01.01,909.02,509.01,714.01,120.0481.0389.0549.0-1,107.01,150.0587.0428.0-6.03,720.0
Issuance of Common Stock78.00.00.00.058.02,550.01,777.01,166.056.066.062.058.0188.0161.0100.0304.0301.0
Repurchase of Common Stock-920.0-425.0-1,150.0-575.0-1,139.0-788.0-469.0-723.0-422.0-194.0-434.0-267.0-200.0-900.0-172.0-497.0-410.0
Dividends Paid-272.00.00.0-265.0-250.0-236.0-222.0-206.0-191.0-170.0-150.0-133.0-176.0-156.0-104.0-1,500.0-747.0
Other Financing Activities-29.00.00.0-55.01,828.0-83.0-41.0-24.0453.0386.0546.0-726.01,178.0591.0395.01,500.01,489.0
Cash from Financing-978.00.00.0-930.0-1,372.0-696.0-717.0-299.0-797.0-202.0-268.0-1,068.0-97.0-554.0-32.0-1,693.0604.0
Cash Flow From Financing Activities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Debt Repaid0.00.00.00.00.00.00.00.00.0-55.0
Debt Issued0.03,409.0-86.0132.0-27.0458.0376.01.0-180.01.0
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock-152.0-85.0-85.0-165.0-90.0-335.0-585.0-230.00.0-80.0
Dividends Paid0.00.00.00.00.00.00.00.00.0-66.0
Other Financing Activities0.00.00.00.00.00.00.00.00.01.0
Cash from Financing0.00.00.00.00.00.00.00.00.0-201.0
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash450.0459.0-261.0537.0-434.043.059.0-866.0-431.0389.0286.0-215.0353.0324.0-1,176.0878.0170.0
Closing Cash Balance1,779.01,791.01,332.01,593.01,056.01,490.01,447.01,388.02,247.02,678.02,289.02,003.03,028.02,675.02,351.03,527.02,649.0
Cash position 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Net Change in Cash-31.0254.048.019.0138.0-450.0108.0-76.0157.0261.0
Closing Cash Balance1,758.01,789.01,537.01,489.01,470.01,332.01,779.01,671.01,748.01,593.0
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow1,417.01,152.01,373.01,474.01,021.01,296.0802.0865.0910.0713.0654.0393.0506.0957.01,035.01,072.0593.0
Real Free Cash Flow1,300.01,024.01,244.01,363.0896.01,186.0719.0793.0840.0653.0596.0339.0410.0873.0961.01,000.0527.0
Free Cash Flow 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Free Cash Flow175.0452.0259.0107.0334.0388.0360.0230.0395.0432.0
Real Free Cash Flow134.0426.0227.077.0294.0363.0332.0198.0351.0418.0
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E24.534.863
P/S4.54.457.8
P/B54.929.8
P/FCF36.624549.4
Market cap$41.4$33.2
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %24.9 %0 %
Debt to Income264.3 %400.8 %0 %
Debt to Free cash flow394.6 %32.3 %0 %
Interest expense percentage7.5 %9.6 %2.9 %
Current ratio2.2 2.6 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE20.3 %16.3 %0 %
ROA10.6 %8.2 %0 %
CapEx to Revenue5.7 %3.3 %0 %
RaD to Revenue0 %8.2 %0 %
ROEM390,331.5 308236.2

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin52.2 %53.1 %47.8 %
Operating margin20.6 %17.1 %28 %
Net margin18.3 %14.3 %19.8 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %1.7 %0 %
Dividend payout percentage0 %40.3 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding284.0 mil 322.3 mil
Employee count18.1 tis 22.0 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader